Defunct Company
Total Trials
18
As Lead Sponsor
16
As Collaborator
2
Total Enrollment
2,783
NCT01232036
Clinical Trial to Compare the Pharmacokinetics and Pharmacodynamics After Oral Administration of Glucophage and HL-018
Phase: Phase 1
Role: Collaborator
Start: May 31, 2010
Completion: Oct 31, 2010
NCT01511874
Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer
Phase: Phase 4
Role: Lead Sponsor
Start: Jan 31, 2011
Completion: Dec 31, 2013
NCT01194037
A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C
Phase: Phase 1/2
Start: Jun 23, 2011
Completion: Nov 28, 2011
NCT01440686
Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers
Start: Sep 30, 2011
Completion: Jan 31, 2012
NCT01541943
Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
Phase: Phase 3
Start: Mar 31, 2012
Completion: Nov 30, 2014
NCT01568489
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
Phase: Phase 2
Start: Apr 9, 2012
Completion: Jun 11, 2013
NCT01806324
A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects
Start: Apr 30, 2012
Completion: Dec 31, 2012
NCT01806363
Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone
Start: Nov 30, 2012
Completion: Jun 30, 2013
NCT01806311
Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg
Start: Dec 31, 2012
Completion: Aug 31, 2013
NCT02717208
Phase 1 Study for Safety and Tolerability of HL036
Start: Feb 29, 2016
Completion: Jun 30, 2016
NCT02988362
Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)
Start: Dec 14, 2016
Completion: Feb 4, 2017
NCT03334539
A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes
Start: Nov 5, 2017
Completion: Apr 9, 2018
NCT03846453
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
Start: Mar 10, 2019
Completion: Nov 22, 2019
NCT04037488
Changes in Body Composition With Patients Under Androgen Deprivation Therapy
Phase: N/A
Start: Aug 31, 2019
Completion: Oct 30, 2021
NCT05109702
A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye
Start: Nov 18, 2021
Completion: May 6, 2022
NCT06088784
A Study Assessing the Safety of Oral ATH-399A in Healthy Adult Participants
Start: Sep 19, 2023
Completion: Apr 24, 2024
NCT06400589
A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye Disease
Start: May 1, 2024
Completion: Aug 31, 2025
NCT06926933
Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious Puberty
Start: Dec 12, 2024
Completion: Oct 30, 2027